Skip to main content
. 2022 Jul 19;14(14):3495. doi: 10.3390/cancers14143495

Figure 1.

Figure 1

Workflow of this study. Investigation of the roles of HSPG2 mutations in evaluating ICI treatment efficacy in melanoma and NSCLC.